Donald J Hayden Jr insider trades: Theseus Pharmaceuticals (THRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Donald reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 30, 2022 | THRX | ↑ Buy | 10,000 | $5.00 | $50K | Direct | Jan 3, 2023 (4d) |
| Feb 10, 2020 | RGNX | ↓ Sell | 24,800 | $50.11 | $1.2M | Direct | Feb 12, 2020 (2d) |
| Feb 5, 2020 | RGNX | ↓ Sell | 2,000 | $50.00 | $100K | Direct | Feb 7, 2020 (2d) |
| Jan 17, 2020 | RGNX | ↓ Sell | 3,200 | $50.01 | $160K | Direct | Jan 21, 2020 (4d) |
| Jan 14, 2020 | RGNX | ↓ Sell | 30,000 | $45.60 | $1.4M | Direct | Jan 16, 2020 (2d) |
| Apr 9, 2019 | INSM | ↓ Sell | 6,286 | $32.99 | $207K | Direct | Apr 11, 2019 (2d) |
| Feb 22, 2019 | INSM | ↓ Sell | 14,900 | $28.08 | $418K | Direct | Feb 26, 2019 (4d) |
| Feb 15, 2019 | INSM | ↓ Sell | 100 | $27.90 | $3K | Direct | Feb 27, 2019 (12d) |
| Jun 5, 2018 | RGNX | ↓ Sell | 15,000 | $55.01 | $825K | Direct | Jun 5, 2018 (0d) |
| May 15, 2018 | RGNX | ↓ Sell | 15,000 | $50.05 | $751K | Direct | May 16, 2018 (1d) |
| May 9, 2018 | RGNX | ↓ Sell | 15,000 | $45.00 | $675K | Direct | May 11, 2018 (2d) |
| Jan 2, 2018 | FOLD | ↓ Sell | 20,000 | $15.00 | $300K | Direct | Jan 4, 2018 (2d) |
| Nov 14, 2017 | INSM | ↓ Sell | 15,000 | $32.50 | $488K | Direct | Nov 16, 2017 (2d) |
| Oct 11, 2017 | RGNX | ↓ Sell | 20,000 | $34.95 | $699K | Direct | Oct 13, 2017 (2d) |
| Sep 27, 2017 | RGNX | ↓ Sell | 20,000 | $32.45 | $649K | Direct | Sep 29, 2017 (2d) |
| Sep 18, 2017 | RGNX | ↓ Sell | 40,000 | $28.70 | $1.1M | Direct | Sep 19, 2017 (1d) |
| Sep 7, 2017 | INSM | ↓ Sell | 30,000 | $29.75 | $893K | Direct | Sep 7, 2017 (0d) |
| Sep 5, 2017 | RGNX | ↓ Sell | 20,000 | $24.95 | $499K | Direct | Sep 7, 2017 (2d) |
| May 15, 2017 | RGNX | ↓ Sell | 8,599 | $19.04 | $164K | Direct | May 17, 2017 (2d) |
| May 8, 2017 | RGNX | ↓ Sell | 10,000 | $18.35 | $184K | Direct | May 10, 2017 (2d) |
| May 1, 2017 | RGNX | ↓ Sell | 30,000 | $22.26 | $668K | Direct | May 3, 2017 (2d) |
| Apr 24, 2017 | RGNX | ↓ Sell | 10,000 | $20.98 | $210K | Direct | Apr 26, 2017 (2d) |
| Mar 21, 2016 | VTAE | ↓ Sell | 16,130 | $7.42 | $120K | Direct | Mar 21, 2016 (0d) |
| Dec 29, 2015 | VTAE | ↓ Sell | 16,130 | $18.00 | $290K | Direct | Dec 30, 2015 (1d) |
| Sep 21, 2015 | VTAE | ↓ Sell | 16,130 | $17.00 | $274K | Direct | Sep 22, 2015 (1d) |
| Sep 2, 2015 | INSM | ↓ Sell | 25,000 | $24.06 | $601K | Direct | Sep 3, 2015 (1d) |
| Jun 23, 2015 | FOLD | ↓ Sell | 55,000 | $14.01 | $770K | Direct | Jun 24, 2015 (1d) |
| May 20, 2015 | VTAE | ↓ Sell | 20,000 | $12.01 | $240K | Direct | May 22, 2015 (2d) |
| Mar 29, 2011 | INSM | ↑ Buy | 2,200 | $6.36 | $14K | Direct | Mar 30, 2011 (1d) |
| Mar 25, 2011 | INSM | ↑ Buy | 10,737 | $5.18 | $56K | Direct | Mar 28, 2011 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Donald J Hayden Jr's insider trades
Donald J Hayden Jr is a director at Theseus Pharmaceuticals (THRX). Since Mar 25, 2011, Donald has reported 3 open-market purchases worth $120K and 27 sales worth $13.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (31 filings), option exercises (26 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every THRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.